For more information, follow the links below to the study listings on www.clinicaltrials.gov.
For more information, follow the links below to the study listings on www.clinicaltrials.gov.
Medical professionals may also email us at AAclinicaltrial_inquiries@concertpharma.com for more information about CTP-543 study participation.
Evaluating the efficacy and safety of CTP-543 in adult patients with moderate to severe alopecia areata.
Status: Recruiting
https://clinicaltrials.gov/ct2/show/NCT04518995
Evaluating the safety and efficacy of CTP-543 in adult patients with chronic, moderate to severe alopecia areata.
Status: Completed
https://clinicaltrials.gov/ct2/show/NCT03137381
Evaluating the efficacy and tolerability of once-daily versus twice-daily dosing of CTP-543, in adult patients with chronic, moderate to severe alopecia areata
Status: Completed
https://clinicaltrials.gov/ct2/show/NCT03941548
Evaluating the efficacy and tolerability of once-daily versus twice-daily dosing of CTP-543, in adult patients with chronic, moderate to severe alopecia areata
Status: Completed
https://clinicaltrials.gov/ct2/show/NCT03811912
Evaluating long-term safety of CTP-543 and to assessing long-term effects of CTP-543 in adult patients with chronic, moderate-to-severe alopecia areata who completed 24 weeks of treatment in a previous qualifying CTP-543 clinical trial.
Status: Active, Not Recruiting
https://clinicaltrials.gov/ct2/show/NCT03898479
Medical professionals may also email us at CNSclinicaltrial_inquiries@concertpharma.com for more information about CTP-692 study participation.
Evaluating the safety and efficacy of CTP-692 in patients with schizophrenia on stable antipsychotic medication.
Status: Active, Not Recruiting
https://clinicaltrials.gov/ct2/show/NCT04158687
Assessing in healthy male and female subjects the safety and pharmacokinetic (PK) profiles of 3 dose levels of CTP-692 following 7 days of dosing.
Status: Completed
https://clinicaltrials.gov/ct2/show/NCT03880253
Concert is committed to developing innovative medicines for autoimmune and CNS disorders.
Participation in our clinical trials plays a vital role in helping develop new medicines. While we do not currently offer investigational therapies outside of our clinical trials, you and your physician may determine that enrolling in a trial may be an option for you. For more information about Concert’s ongoing clinical trial programs, please reference the trials listed above.